Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Zoledronic Acid Inhibits the C...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Zoledronic Acid Inhibits the Capacity of Myeloid-Immune Suppressor Cells in Myeloma to Form Osteoclasts.
Bibliographic Details
Main Authors:
Zhuang, J
,
Edwards, C
,
Zhang, J
,
Lwin, S
,
Mundy, G
Format:
Conference item
Published:
2008
Holdings
Description
Similar Items
Staff View
Similar Items
Osteoclasts in Myeloma Are Derived from Gr-1(+)CD11b(+) Myeloid Immune Suppressor Cells of the Bone Marrow Niche in Vivo
by: Zhuang, J, et al.
Published: (2008)
Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells
by: Zhuang, J, et al.
Published: (2012)
Zoledronic acid prevents the development of myeloma bone disease and increases survival
by: Shipman, C, et al.
Published: (2002)
Osteoclasts in myeloma are derived from Gr-1+CD11b+mononuclear cells of the bone marrow niche
by: Zhuang, J, et al.
Published: (2007)
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
by: Croucher, P, et al.
Published: (2001)